|
Delayed
Nasdaq Stockholm
03:01:37 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.698 SEK | +1.31% |
|
+10.98% | -13.81% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 249M 26.25M 22.66M 21.26M 19.37M 36.41M 2.51B 36.92M 97.67M 1.26B 98.56M 96.42M 4.18B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 249M 26.25M 22.66M 21.26M 19.37M 36.41M 2.51B 36.92M 97.67M 1.26B 98.56M 96.42M 4.18B | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 1.76x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| 1 day | +1.31% | ||
| 1 week | +10.98% | ||
| Current month | +28.83% | ||
| 1 month | +34.98% | ||
| 3 months | +33.91% | ||
| 6 months | -0.82% | ||
| Current year | -13.81% |
| 1 week | 1.52 |  | 1.7 |
| 1 month | 1.23 | | 1.7 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.15 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 62.4 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
| Chairman | 68 | 2023-02-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Buy | Chairman | 31,000 | 38.8588% | ||
| 7/1/26 | Buy | Chief Technology Officer | 4,016,742 | 5,035.0256% | ||
| 7/1/26 | Buy | Chief Executive Officer | 183,858 | 230.4678% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | +10.98% | -44.33% | -77.36% | 26.25M | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,055B | |
| +0.78% | +0.21% | +48.53% | +50.78% | 632B | |
| +0.35% | +0.95% | +21.11% | +66.86% | 442B | |
| +1.01% | -4.56% | +39.10% | +38.05% | 351B | |
| +0.19% | -2.68% | +24.03% | +37.32% | 290B | |
| +0.15% | -2.36% | -1.48% | +8.50% | 243B | |
| +1.00% | +0.52% | +41.46% | +58.95% | 227B | |
| -0.76% | -6.09% | -16.98% | -53.88% | 200B | |
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | |
| Average | +0.48% | -0.20% | +19.75% | +33.09% | 361.25B | |
| Weighted average by Cap. | +0.42% | -1.87% | +39.26% | +63.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.74M 9.27M 8.7M 7.93M 14.9M 1.03B 15.11M 39.97M 515M 40.33M 39.46M 1.71B | 142M 14.94M 12.89M 12.1M 11.02M 20.72M 1.43B 21M 55.57M 715M 56.07M 54.86M 2.38B |
| Net income | -32.6M -3.43M -2.96M -2.78M -2.53M -4.76M -328M -4.83M -12.77M -164M -12.89M -12.61M -547M | 33.3M 3.51M 3.03M 2.84M 2.59M 4.86M 335M 4.93M 13.05M 168M 13.17M 12.88M 559M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | SEK 1.698 | +1.31% | 108,861 |
| 26-08-17 | SEK 1.676 | +1.70% | 2,318,081 |
| 26-08-14 | SEK 1.648 | +1.73% | 1,337,981 |
| 26-08-13 | SEK 1.620 | +2.92% | 1,817,776 |
| 26-08-12 | SEK 1.574 | +2.88% | 4,261,996 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
